The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 27, 2020
Filed:
Nov. 13, 2014
Applicant:
The Doshisha, Kyoto, JP;
Inventors:
Assignee:
THE DOSHISHA, Kyoto-shi, Kyoto, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4439 (2006.01); A61K 31/455 (2006.01); A61K 31/167 (2006.01); A61K 31/437 (2006.01); A61K 31/44 (2006.01); A61K 31/4418 (2006.01); A61K 31/5377 (2006.01); A61K 31/4155 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4439 (2013.01); A61K 31/167 (2013.01); A61K 31/4155 (2013.01); A61K 31/437 (2013.01); A61K 31/44 (2013.01); A61K 31/4418 (2013.01); A61K 31/5377 (2013.01);
Abstract
Provided is an agent for treating or preventing a corneal endothelial disorder wherein cell proliferation is required. More specifically, provided is an agent for treating or preventing a corneal endothelial disorder, wherein cell proliferation is required, said agent comprising a p38MAP kinase inhibitor. In a preferred embodiment, the corneal endothelial disorder is a wound. In a preferred embodiment, the p38MAP kinase inhibitor is soluble in water. The p38MAP kinase inhibitor may comprise 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole (SB203580) or a salt thereof.